E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/4/2022 in the Prospect News Structured Products Daily.

New Issue: GS Finance sells additional $3.01 million equity-linked notes on AbbVie

Chicago, April 4 – GS Finance Corp. sold an additional $3.01 million of 0% equity-linked notes due May 1, 2028 tied to the common stock of AbbVie Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes are guaranteed by Goldman Sachs Group, Inc.

The payout at maturity will be the greater of 7.3174 times the closing price of the shares per each $1,000 principal amount of notes and par.

The 7.3174 exchange rate is the quotient of (i) 1,000 divided by (ii) the product of (a) 1.225 times (b) the initial share price of $111.5591 (which is higher than the actual closing price of the stock on the trade date, which is $111.38).

Goldman Sachs & Co. LLC is the underwriter.

Issuer:GS Finance Corp.
Guarantor:Goldman Sachs Group, Inc.
Issue:Equity-linked notes
Underlying stock:AbbVie Inc.
Amount:$3,007,000
Maturity:May 1, 2028
Coupon:0%
Price:Par
Payout at maturity:Greater of par of $1,000 and 7.3174 times the final share price
Initial share price:$111.5591
Pricing date:May 5, 2021
Settlement date:May 7, 2021
Underwriter:Goldman Sachs & Co. LLC
Fees:0.9298%
Original notes:$20.05 million priced on April 23 and settled April 30
Cusip:40057H4D9

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.